Results 31 to 40 of about 1,010,901 (298)

18F-fluciclovine (Axumin) PET/CT detecting occult bone metastasis

The Egyptian Journal of Radiology and Nuclear Medicine, 2020
Background 18F-fluciclovine (Axumin) positron emission tomography (PET) is a novel agent for detection of biochemical recurrence of the prostate cancer.
Pankaj Nepal, Paul Rodrigue, Thomas Olsavsky   +2 more
doaj   +1 more source

The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer [PDF]

Urologic Clinics of North America, 2020
Biochemically recurrent prostate cancer represents a stage of prostate cancer where conventional (continued on next page) computed tomography and technetium Tc 99m bone scan imaging are unable to detect disease after curative intervention despite rising prostate-specific antigen. There is no clear standard of care and no systemic therapy has been shown
Marijo, Bilusic, David J, Einstein, Fatima H, Karzai, William L, Dahut, James L, Gulley, Jeanny B, Aragon-Ching, Ravi A, Madan   +6 more
openaire   +2 more sources

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Radiation Oncology, 2018
Background PSMA PET/CT visualises prostate cancer residual disease or recurrence at lower PSA levels compared to conventional imaging and results in a change of treatment in a remarkable high number of patients.
Nina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, Annika Herlemann, Alexander Buchner, Christian Stief, Chukwuka Eze, Paul Rogowski, Minglun Li, Peter Bartenstein, Ute Ganswindt, Claus Belka   +11 more
doaj   +1 more source

Recurrence coefficients for discrete orthonormal polynomials and the Painlevé equations [PDF]

, 2013
We investigate semi-classical generalizations of the Charlier and Meixner polynomials, which are discrete orthogonal polynomials that satisfy three-term recurrence relations.
Clarkson, Peter
core   +1 more source

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy

Prostate International, 2016
Background: The Gleason grading system is a powerful predictor of prostate cancer (PCa) prognosis. Gleason scores (GS) of 8–10 are considered as a single high-risk grade category, and Gleason Pattern 5 (GP5) predicts biochemical recurrence. We report the
Tomoyuki Makino, Sotaro Miwa, Kiyoshi Koshida   +2 more
doaj   +1 more source

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer. [PDF]

, 2008
Contains fulltext : 69173.pdf (Publisher’s version ) (Open Access)OBJECTIVES: Previous studies suggest that maximum tumor diameter (MTD) is a predictor of recurrence in prostate cancer (PC).
C. A. Hulsbergen-vandeKaa, Oort, I.M. van, L. A. L. M. Kiemeney, Kok, D.E.G., D. E. G. Kok, van Oort, I.M., I. M. van Oort, Kok, D.E., Kiemeney, L.A.L.M., Hulsbergen-van de Kaa, C.A., Kiemeney, L.A., Oort, I.M., van, Witjes, J.A., J. A. Witjes   +13 more
core   +2 more sources

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence

Frontiers in Endocrinology, 2022
Prostate cancer (PCa) induced death is the predominant cause of cancer-related death among men in 48 countries. After radical treatment, biochemical recurrence has become an important factor for prognosis.
Jie Jiang, Xiaoxia Tang, Yongzhu Pu, Yong Yang, Conghui Yang, Fake Yang, Yadong Tian, Jindan Li, Hua Sun, Sheng Zhao, Long Chen   +10 more
doaj   +1 more source

Predictive Role of De Ritis Ratio in Biochemical Recurrence After Radical Prostatectomy

Haseki Tıp Bülteni, 2020
Aim:To analyze the role of De Ritis (aspartate aminotransferase/alanine aminotransferase) ratio in predicting biochemical recurrence (BCR) after radical prostatectomy (RP).Methods:We retrospectively evaluated 425 patients with localised prostate cancer ...
Kaan Karamık, Yasin Aktaş, Ali Yıldız, İbrahim Erol, Ekrem İslamoğlu, Mutlu Ateş, Taha Ölçücü, Kayhan Yılmaz, Murat Savaş   +8 more
doaj   +1 more source

Assessment of biochemical recurrence of prostate cancer (Review)

International Journal of Oncology, 2019
The assessment of the risk of biochemical recurrence (BCR) is critical in the management of males with prostate cancer (PC). Over the past decades, a comprehensive effort has been focusing on improving risk stratification; a variety of models have been constructed using PC‑associated pathological features and molecular alterations occurring at the ...
Lin, Xiaozeng, Kapoor, Anil, Gu, Yan, Chow, Mathilda Jing, Xu, Hui, Major, Pierre, Tang, Damu   +6 more
openaire   +3 more sources

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence [PDF]

Cancer, 2010
AbstractBACKGROUND:Postprostatectomy adjuvant or salvage radiotherapy, when using standard fractionation, requires 6.5 to 8 weeks of treatment. The authors report on the safety and efficacy of an expedited radiotherapy course for salvage prostate radiotherapy.METHODS:A total of 108 consecutive patients were treated with salvage radiation therapy to 65 ...
Tim J, Kruser, David F, Jarrard, Andrew K, Graf, Sean P, Hedican, David R, Paolone, John D, Wegenke, Glenn, Liu, Heather M, Geye, Mark A, Ritter   +8 more
openaire   +2 more sources